SG Americas Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Buy
243,447
+150,206
+161% +$8.26M 0.06% 231
2025
Q1
$6.59M Buy
93,241
+87,789
+1,610% +$6.21M 0.02% 365
2024
Q4
$358K Sell
5,452
-818
-13% -$53.7K ﹤0.01% 1438
2024
Q3
$441K Sell
6,270
-1,134
-15% -$79.8K ﹤0.01% 1591
2024
Q2
$610K Sell
7,404
-28,078
-79% -$2.31M ﹤0.01% 1425
2024
Q1
$3.1M Buy
+35,482
New +$3.1M 0.01% 667
2023
Q4
Sell
-4,957
Closed -$439K 2762
2023
Q3
$439K Sell
4,957
-2,893
-37% -$256K 0.01% 1708
2023
Q2
$680K Buy
7,850
+4,919
+168% +$426K 0.01% 1116
2023
Q1
$285K Sell
2,931
-9,614
-77% -$935K ﹤0.01% 1964
2022
Q4
$1.3M Buy
12,545
+10,832
+632% +$1.12M 0.02% 693
2022
Q3
$145K Sell
1,713
-27,364
-94% -$2.32M ﹤0.01% 2293
2022
Q2
$2.41M Sell
29,077
-38,363
-57% -$3.18M 0.03% 538
2022
Q1
$5.2M Buy
67,440
+37,740
+127% +$2.91M 0.04% 342
2021
Q4
$2.62M Buy
29,700
+28,152
+1,819% +$2.49M 0.01% 792
2021
Q3
$120K Sell
1,548
-5,953
-79% -$461K ﹤0.01% 3303
2021
Q2
$626K Sell
7,501
-4,007
-35% -$334K ﹤0.01% 1663
2021
Q1
$869K Sell
11,508
-6,156
-35% -$465K ﹤0.01% 1492
2020
Q4
$1.55M Sell
17,664
-43,792
-71% -$3.84M 0.01% 1100
2020
Q3
$4.68M Sell
61,456
-26,112
-30% -$1.99M 0.03% 287
2020
Q2
$10.8M Buy
87,568
+76,441
+687% +$9.43M 0.09% 119
2020
Q1
$940K Sell
11,127
-3,184
-22% -$269K 0.01% 1072
2019
Q4
$1.21M Sell
14,311
-83,111
-85% -$7.03M 0.01% 995
2019
Q3
$6.57M Buy
97,422
+82,669
+560% +$5.57M 0.05% 326
2019
Q2
$1.26M Buy
14,753
+931
+7% +$79.8K 0.01% 1163
2019
Q1
$1.23M Buy
+13,822
New +$1.23M 0.01% 1024
2018
Q4
Sell
-28,094
Closed -$2.72M 2456
2018
Q3
$2.72M Buy
28,094
+18,988
+209% +$1.84M 0.02% 839
2018
Q2
$858K Buy
9,106
+1,327
+17% +$125K 0.01% 1416
2018
Q1
$631K Buy
7,779
+1,025
+15% +$83.1K 0.01% 1494
2017
Q4
$602K Buy
6,754
+5,168
+326% +$461K 0.01% 1482
2017
Q3
$148K Sell
1,586
-347
-18% -$32.4K ﹤0.01% 2486
2017
Q2
$176K Sell
1,933
-22,258
-92% -$2.03M ﹤0.01% 2218
2017
Q1
$2.12M Sell
24,191
-16,765
-41% -$1.47M 0.02% 792
2016
Q4
$3.39M Buy
40,956
+26,995
+193% +$2.24M 0.03% 608
2016
Q3
$1.29M Sell
13,961
-18,411
-57% -$1.7M 0.01% 887
2016
Q2
$2.52M Buy
32,372
+6,794
+27% +$529K 0.02% 645
2016
Q1
$2.11M Sell
25,578
-47,830
-65% -$3.95M 0.02% 756
2015
Q4
$7.69M Sell
73,408
-6,868
-9% -$719K 0.05% 252
2015
Q3
$5.98M Buy
80,276
+27,919
+53% +$2.08M 0.04% 325
2015
Q2
$7.16M Buy
52,357
+4,543
+10% +$621K 0.05% 244
2015
Q1
$5.96M Sell
47,814
-977
-2% -$122K 0.04% 324
2014
Q4
$4.41M Buy
48,791
+24,131
+98% +$2.18M 0.02% 606
2014
Q3
$1.78M Buy
24,660
+22,619
+1,108% +$1.63M 0.01% 850
2014
Q2
$127K Sell
2,041
-15,191
-88% -$945K ﹤0.01% 1946
2014
Q1
$1.18M Buy
17,232
+7,357
+75% +$502K 0.01% 1014
2013
Q4
$694K Buy
9,875
+422
+4% +$29.7K ﹤0.01% 1237
2013
Q3
$683K Buy
+9,453
New +$683K ﹤0.01% 1317